Systematic Review

Accepted on 05 Dec 2023

Intestinal Microbiome-targeted Therapies improve Liver Function in Alcohol-related Liver disease by restoring Bifidobacteria：a Systematic Review and Meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Xin Chi
Xiu Sun
Danying Cheng
Shunai Liu
Calvin Q Pan
Huichun Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274261

Review

Accepted on 04 Dec 2023

Macrophage cytotherapy on liver cirrhosis

in Gastrointestinal and Hepatic Pharmacology

Dabing Ping
Yuan Peng
Xudong Hu
Chenghai Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265935

Mini Review

Published on 01 Dec 2023

The regulatory role and mechanism of exosomes in hepatic fibrosis

in Gastrointestinal and Hepatic Pharmacology

Youli Yao
Da Chen
Zengchang Yue

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1284742

300 views

Systematic Review

Accepted on 30 Nov 2023

Effect of potassium-competitive acid blockers on human gut microbiota: A systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Meng-Ling Ouyang
Shu-Peng Zou
Qian Cheng
Xuan Shi
Ya-Zheng Zhao
Minghui Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1269125

Correction

Accepted on 30 Nov 2023

Corrigendum: [Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis]

in Gastrointestinal and Hepatic Pharmacology

Jin XIAO
Yan-Ni Zhou
Yan-Lin Yang
Li He
Ke-Kai Wang
Min Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1330698

Review

Accepted on 28 Nov 2023

Research progress of traditional Chinese medicine in improving hepatic fibrosis based on inhibiting pathological angiogenesis

in Gastrointestinal and Hepatic Pharmacology

Zhen Li
Junfeng Zhu
Hao Ouyang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1303012

Original Research

Accepted on 28 Nov 2023

Cholecystectomy is associated with a higher risk of irritable bowel syndrome in the UK Biobank: Aa prospective cohort study

in Gastrointestinal and Hepatic Pharmacology

Jinyu Zhao
Liang Tian
Bin Xia
Ningning Mi
Qiangsheng He
Man Yang
Danni Wang
Wu Siqing
Zijun Li
Shiyong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1244563

Original Research

Published on 22 Nov 2023

Solanum aethiopicum L. from the Basilicata region as a source of specialized metabolites with promising anti-obesity effects: phytochemical characterization and in vivo investigation in high fat diet-fed mice

in Gastrointestinal and Hepatic Pharmacology

Maria Ponticelli
Laura Hidalgo-García
Patricia Diez-Echave
Teresa Vezza
Miguel Romero
Iñaki Robles-Vera
Juan Duarte
Filomena De Biasio
Domenico Gorgoglione
Ludovica Lela

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1306135

201 views

Original Research

Published on 20 Nov 2023

Increased sinusoidal export of drug glucuronides is a compensative mechanism in liver cirrhosis of mice

in Gastrointestinal and Hepatic Pharmacology

Rebekka Fendt
Ahmed Ghallab
Maiju Myllys
Ute Hofmann
Reham Hassan
Zaynab Hobloss
Daniela González
Lisa Brackhagen
Rosemarie Marchan
Karolina Edlund

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1279357

337 views

Original Research

Published on 17 Nov 2023

Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS)

in Gastrointestinal and Hepatic Pharmacology

Lin Zhang
Wei Mao
Dan Liu
Bin Hu
Xiaofang Lin
Jie Ran
Xingxing Li
Jing Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1231320

343 views

Original Research

Published on 16 Nov 2023

Minocycline synergizes with corticosteroids in reducing colitis severity in mice via the modulation of pro-inflammatory molecules

in Gastrointestinal and Hepatic Pharmacology

Maitham A. Khajah
Sanaa Hawai
Ahmad Barakat
Aisha Albaloushi
Maha Alkharji
Willias Masocha

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1252174

354 views

Systematic Review

Published on 15 Nov 2023

Efficacy and safety of sedation with dexmedetomidine in adults undergoing gastrointestinal endoscopic procedures: systematic review and meta-analysis of randomized controlled trials

in Gastrointestinal and Hepatic Pharmacology

Rou Tang
Yaqun Huang
Yujia Zhang
Xiaolei Ma
Haoyang Yu
Kaichao Song
Ling Ren
Bin Zhao
Lulu Wang
Wensheng Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1241714

289 views

Correction

Published on 13 Nov 2023

Corrigendum: Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes

in Gastrointestinal and Hepatic Pharmacology

Chao Jin
Bei-Bei Gao
Wen-Jing Zhou
Bao-Jing Zhao
Xing Fang
Chun-Lan Yang
Xiao-Hua Wang
Quan Xia
Ting-Ting Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1322549

208 views

Review

Published on 09 Nov 2023

Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs

in Gastrointestinal and Hepatic Pharmacology

Baoqiang Zhu
Yuankui Wei
Mingming Zhang
Shiyu Yang
Rongsheng Tong
Wenyuan Li
Enwu Long

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1286449

428 views

Clinical Trial

Published on 07 Nov 2023

Efficacy and safety of high-dose ilaprazole-amoxicillin dual therapy for Helicobacter pylori eradication: a prospective, single-center, randomized trial

in Gastrointestinal and Hepatic Pharmacology

Jianping Cheng
Chanjuan Fan
Kun Huang
Lili Zhai
Hui Wang
Dongling Xie
Yong Cai
Zhen Li
Qixuan Bai
Pan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1272744

329 views

Original Research

Published on 03 Nov 2023

Characteristics of the gut microbiome and metabolic profile in elderly patients with sarcopenia

in Gastrointestinal and Hepatic Pharmacology

Jing Zhou
Jiang Liu
Qinqing Lin
Linhui Shi
Zhigang Zeng
Lichang Guan
Yunzi Ma
Yingtong Zeng
Shilong Zhong
Lishu Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1279448

658 views

Navigation group

Articles

Intestinal Microbiome-targeted Therapies improve Liver Function in Alcohol-related Liver disease by restoring Bifidobacteria：a Systematic Review and Meta-analysis

Macrophage cytotherapy on liver cirrhosis

The regulatory role and mechanism of exosomes in hepatic fibrosis

Effect of potassium-competitive acid blockers on human gut microbiota: A systematic review and meta-analysis

Corrigendum: [Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis]

Research progress of traditional Chinese medicine in improving hepatic fibrosis based on inhibiting pathological angiogenesis

Cholecystectomy is associated with a higher risk of irritable bowel syndrome in the UK Biobank: Aa prospective cohort study

Solanum aethiopicum L. from the Basilicata region as a source of specialized metabolites with promising anti-obesity effects: phytochemical characterization and in vivo investigation in high fat diet-fed mice

Increased sinusoidal export of drug glucuronides is a compensative mechanism in liver cirrhosis of mice

Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS)

Minocycline synergizes with corticosteroids in reducing colitis severity in mice via the modulation of pro-inflammatory molecules

Efficacy and safety of sedation with dexmedetomidine in adults undergoing gastrointestinal endoscopic procedures: systematic review and meta-analysis of randomized controlled trials

Corrigendum: Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes

Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs

Efficacy and safety of high-dose ilaprazole-amoxicillin dual therapy for Helicobacter pylori eradication: a prospective, single-center, randomized trial

Characteristics of the gut microbiome and metabolic profile in elderly patients with sarcopenia